| Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation (NCT00253214) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-03-01 |
| Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) (NCT00007189) | Seattle Institute for Biomedical and Clinical Research | 2001-01-01 |
| Alzheimer's in Long-Term Care--Treatment for Agitation (NCT00161473) | University of Washington | 2001-01-01 |
| COGNIShunt® System for Alzheimer's Disease (NCT00056628) | Eunoe | 2001-01-01 |
| Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease (NCT00034762) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-12-01 |
| Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs (NCT00065169) | University of California, Los Angeles | 2000-11-01 |
| Lipitor as a Treatment for Alzheimer's Disease (NCT00024531) | Institute for the Study of Aging (ISOA) | 2000-10-01 |
| Effect of Indomethacin on the Progression of Alzheimer's Disease (NCT00432081) | Radboud University Medical Center | 2000-05-01 |
| Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type (NCT00036114) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-03-01 |
| Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease (NCT00304629) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-03-01 |
| Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type (NCT00041678) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-01-01 |
| Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249351) | Boehringer Ingelheim | 1999-12-01 |
| Insulin, Neurogenetics and Memory in Alzheimer's Disease (NCT00018382) | US Department of Veterans Affairs | 1999-10-01 |
| Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease (NCT00006399) | National Center for Research Resources (NCRR) | 1999-09-01 |
| Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease (NCT00467766) | Pfizer | 1999-07-01 |
| Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type (NCT02248116) | Boehringer Ingelheim | 1999-05-01 |
| The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients (NCT00480870) | Associacao Fundo de Incentivo a Psicofarmcologia | 1999-04-01 |
| Memory Impairment Study (Mild Cognitive Impairment Study) (NCT00000173) | National Institute on Aging (NIA) | 1999-03-01 |
| Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249403) | Boehringer Ingelheim | 1999-01-01 |
| A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia (NCT00261573) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1998-12-01 |
| Electrophysiologic Measures of Treatment Response in Alzheimer Disease (NCT00018278) | US Department of Veterans Affairs | 1998-10-01 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00249158) | Janssen-Cilag Pty Ltd | 1998-03-01 |
| A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253227) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-07-01 |
| A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253188) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-02-01 |
| Coordinating Center for Enhancing ADRD Caregiving (NCT00178165) | University of Pittsburgh | 1996-09-01 |
| Estrogen Hormone Protocol (NCT00000177) | National Institute on Aging (NIA) | 1995-10-01 |
| Serotonergic Pharmacotherapy for Agitation of Dementia (NCT00009204) | Bruce Pollock | 1995-09-01 |
| A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00249145) | Janssen Pharmaceutica N.V., Belgium | 1995-04-01 |
| Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease (NCT00013923) | National Institute on Aging (NIA) | |
| TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease (NCT03539380) | TauRx Therapeutics Ltd | |
| Determinants of Quality of Life Related to Health in Alzheimer Disease (NCT01570322) | CHU de Reims | |
| Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) (NCT01822951) | Ever Neuro Pharma GmbH | |
| The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease (NCT00006187) | Merck Sharp & Dohme LLC | |
| Study of Melatonin: Sleep Problems in Alzheimer's Disease (NCT00000171) | National Institute on Aging (NIA) | |
| Alzheimer's Disease Prevention Trial (NCT00000176) | National Institute on Aging (NIA) | |
| Expanded Access to Provide SUVN-502 for the Treatment of Subjects With Alzheimer's Disease (NCT03564964) | Suven Life Sciences Limited | |
| TB006 Expanded Access (EA) Compassionate Use (NCT05959239) | TrueBinding, Inc. | |
| Evaluation of Galantamine in the Treatment of Alzheimer's Disease (NCT00000172) | Janssen, LP | |
| A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease (NCT00035204) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia (NCT00253123) | Janssen, LP | |
| A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) (NCT00004845) | National Institute on Aging (NIA) | |
| Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients (NCT00281749) | Maimonides Medical Center | |
| Multicenter Trial of Prednisone in Alzheimer's Disease (NCT00000178) | National Institute on Aging (NIA) | |
| Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease (NCT04855955) | Celltex Therapeutics Corporation | |
| Using Hypnotherapy For Dementia & Alzheimer's (NCT01435551) | Families To The Rescue | |
| Healthy Aging and Memory Study (NCT00034567) | National Institute on Aging (NIA) | |
| Gene Therapy for Alzheimer's Disease Clinical Trial (NCT00017940) | The Shiley Family Trust | |
| Agitation in Alzheimer's Disease (NCT00000179) | National Institute on Aging (NIA) | |
| Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) (NCT00000174) | Novartis | |
| A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease (NCT00253201) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |